Omeros Corporation.
company in Seattle, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 30
What's happening
Earlier this month
-
EMA adopted a negative opinion on MAA for Omeros Corporation, while Pomerantz LLP confirmed its global office locations.Some support2 reports
-
Omeros Corporation's drug received FDA approval and is currently undergoing review by the European Medicines Agency.Some support2 reports1 development inside
One to three months ago
Gone quiet
No new reports in 90+ days-
Omeros Corporation, based in Seattle, has submitted a Biologics License Application (BLA) to the FDA seeking approval for its drug candidate, narsoplimab.Some support4 reports1 development inside
-
Omeros Corporation analysts expect the company to reach breakeven soon, while Trump pledged to unleash American oil and gas.Speculative1 report
-
BlackRock became the largest shareholder in Omeros Corporation on August 12, 2025, while Gregory Demopulos was appointed CEO.Some support1 report
-
Omeros Corporation is based in Seattle.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Omeros Corporation this week
News at the entities that move Omeros Corporation most-
FDA StructuralFDA approval coincided with Donald Trump's press conference on November 11, 2026.Moves Omeros Corporation
-
SEC StructuralContinuum Advisory LLC bought a stake in the Unusual Whales Subversive Democratic Trading ETF and filed Form 13F with the SEC.Moves Omeros Corporation
-
Seattle Shared contextSeattle Public Utilities plans to build a hub in North Seattle, leading to the displacement of Thompson's business.Moves Omeros Corporation
-
Chicago Shared contextAmish Shah joined the New Democrat Coalition, obtained a degree from UC Berkeley, and was born in Chicago.Moves Omeros Corporation
-
New York City Shared contextGarrido advised on a city health system failure in New York City while Mamdani faced union workers over a contract.Moves Omeros Corporation
-
Los Angeles Shared contextFlorence's technology sector is expanding its reach, attracting Canadian cities and growing into Los Angeles.Moves Omeros Corporation
Connections
The 11 strongest of 30, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Omeros Corporation's drug candidates require formal regulatory review and approval from the FDA.
-
European Medicines Agency Structural
EMA reviewed Omeros's marketing authorization application and issued a negative opinion on the application.
-
SEC Structural
Omeros Corporation is subject to the regulatory oversight and disclosure requirements of the SEC.
-
National Institute on Drug Abuse Structural
NIDA provides financial funding to Omeros Corporation for the development of its drug candidate OMS527.
-
Seattle Shared context
Omeros Corporation is consistently reported as being based in Seattle.
-
Chicago Shared context
Omeros Corporation is located within the geographic context of Chicago.
-
Los Angeles Shared context
Omeros Corporation is located within the geographical context of Los Angeles.
-
New York City Shared context
Omeros Corporation is subject to a legal investigation taking place in New York City.
Show all 11 connections
-
Paris Mentioned together
No evidence found linking Paris and Omeros Corporation.
-
London Mentioned together
The provided evidence does not describe any relationship between Omeros Corporation and London.
-
New York Mentioned together
No evidence linking New York and Omeros Corporation was found in the provided timeline.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
2 eventsJune 2026
5 events- Omeros Corporation's drug received FDA approval and is currently undergoing review by the European Medicines Agency.
- Omeros Corporation, based in Seattle, has submitted a Biologics License Application (BLA) to the FDA seeking approval for its drug candidate, narsoplimab.
- Omeros Corporation analysts expect the company to reach breakeven soon, while Trump pledged to unleash American oil and gas.
- BlackRock became the largest shareholder in Omeros Corporation on August 12, 2025, while Gregory Demopulos was appointed CEO.
- Omeros Corporation is based in Seattle.